Pregnancy and the Hair Growth Cycle: Anagen Induction Against Hair Growth Disruption Using Nourkrin with Marilex, a Proteoglycan Replacement Therapy

    September 2016 in “ Journal of Cosmetic Dermatology
    Erling Thom
    Image of study
    TLDR Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.
    The document from 2016 examines postpartum effluvium, a condition causing hair loss after childbirth due to hormonal changes that disrupt the hair growth cycle. It highlights the role of proteoglycans in hair follicle health and how their levels drop, along with a rise in cortisol levels, during and after pregnancy. The paper presents Nourkrin® with Marilex®, a proteoglycan replacement therapy, as a potential treatment to induce the anagen phase and combat hair loss. A double-blind placebo-controlled trial mentioned in the document showed a 35.7% increase in hair count over 6 months with this therapy. The paper calls for more research into the biological mechanisms of postpartum effluvium to create targeted treatments for long-term hair preservation.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results

    Related Community Posts Join

    6 / 10 results

    Related Research

    7 / 7 results